Apogee Therapeutics Inc (APGE)

Nov 19, 2024

Victory Capital Management Inc. Grows Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat

Nov 19, 2024

Nov 19, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 19, 2024

Nov 18, 2024

Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024 - Marketscreener.com

Nov 18, 2024

Nov 18, 2024

Apogee Therapeutics Unveils First R&D Day: Spotlight on APG777 and Immunology Pipeline | APGE Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Wedbush Cuts Earnings Estimates for Apogee Therapeutics - MarketBeat

Nov 15, 2024

Nov 14, 2024

Driehaus Capital Management LLC Acquires Shares in Apogee Therap - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Stifel maintains Buy on Apogee Therapeutics with $95 target By Investing.com - Investing.com Australia

Nov 14, 2024

Nov 13, 2024

Stifel maintains Buy on Apogee Therapeutics with $95 target - Investing.com India

Nov 13, 2024

Nov 13, 2024

FMR LLC Adjusts Stake in Apogee Therapeutics Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Apogee Therapeutics Highlights Pipeline Progress and Financials - TipRanks

Nov 12, 2024

Nov 12, 2024

APGEApogee Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024

Nov 12, 2024

Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 12, 2024

Nov 10, 2024

Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis - Seeking Alpha

Nov 10, 2024

Nov 09, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Insider Carl Dambkowski Sells 6,665 Shares - MarketBeat

Nov 09, 2024

Nov 09, 2024

Michael Thomas Henderson Sells 15,000 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) Stock - MarketBeat

Nov 09, 2024

Nov 09, 2024

Apogee Therapeutics Inc (APGE) Worth Considering For The Next Few Weeks - Stocks Register

Nov 09, 2024

Nov 09, 2024

Apogee Therapeutics chief medical officer sells shares worth $394,041 By Investing.com - Investing.com South Africa

Nov 09, 2024

Nov 08, 2024

Insider Sale at Apogee Therapeutics Inc (APGE): Chief Medical Of - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Apogee Therapeutics chief medical officer sells shares worth $394,041 - Investing.com India

Nov 08, 2024

Nov 08, 2024

Apogee Therapeutics CEO sells shares worth $888,320 - Investing.com

Nov 08, 2024

Nov 06, 2024

(APGE) Proactive Strategies - Stock Traders Daily

Nov 06, 2024

Nov 06, 2024

Apogee Therapeutics (NASDAQ:APGE) and Fennec Pharmaceuticals (NASDAQ:FENC) Financial Contrast - Defense World

Nov 06, 2024

Nov 05, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World

Nov 05, 2024

Nov 04, 2024

Apogee Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewswire

Nov 04, 2024

Oct 31, 2024

Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive

Oct 31, 2024

Oct 31, 2024

10 Best IPO Stocks To Buy Heading into 2025 - Insider Monkey

Oct 31, 2024

Oct 27, 2024

(APGE) Investment Analysis and Advice - Stock Traders Daily

Oct 27, 2024

Oct 25, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Oct 25, 2024

Oct 25, 2024

Wedbush Reiterates Outperform Rating for Apogee Therapeutics (NASDAQ:APGE) - MarketBeat

Oct 25, 2024

Oct 24, 2024

Apogee Therapeutics Unveils Promising Phase 1 Trial Results - TipRanks

Oct 24, 2024

Oct 24, 2024

Apogee Therapeutics Announces Results Up to 9 Months from - GlobeNewswire

Oct 24, 2024

Oct 24, 2024

Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel - The Bakersfield Californian

Oct 24, 2024

Oct 24, 2024

Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases - StockTitan

Oct 24, 2024

Oct 20, 2024

Waypoint Capital Advisors LLC Invests $36.84 Million in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat

Oct 20, 2024

Oct 18, 2024

Apogee Therapeutics (NASDAQ:APGE) Trading Down 4.1%Here's What Happened - MarketBeat

Oct 18, 2024

Oct 16, 2024

(APGE) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 16, 2024

Oct 16, 2024

Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting - GlobeNewswire

Oct 16, 2024

Oct 16, 2024

11,535 Shares in Apogee Therapeutics, Inc. (NASDAQ:APGE) Acquired by AQR Capital Management LLC - MarketBeat

Oct 16, 2024

Oct 15, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Short Interest Down 11.7% in September - MarketBeat

Oct 15, 2024

Oct 14, 2024

Millennium Management LLC Lowers Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat

Oct 14, 2024

Oct 09, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat

Oct 09, 2024

Oct 08, 2024

Analyzing Apogee Therapeutics Inc. (APGE) After Recent Trading Activity - Knox Daily

Oct 08, 2024

Oct 08, 2024

Ratio Examination: Apogee Therapeutics Inc. (APGE)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 08, 2024

Oct 07, 2024

Apogee Therapeutics, Inc. (APGE): A Hot Stock to Buy Now - Insider Monkey

Oct 07, 2024

Oct 05, 2024

Squarepoint Ops LLC Purchases 25,829 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat

Oct 05, 2024

Oct 05, 2024

Apogee Therapeutics Inc CEO Michael Henderson Sells 40,000 Shares - GuruFocus.com

Oct 05, 2024